Literature DB >> 17539192

Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539192     DOI: 10.1016/s1533-0028(11)70480-7

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  6 in total

1.  In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.

Authors:  Heidi Colville; Ryan Dzadony; Rebecca Kemp; Stephen Stewart; Herbert J Zeh; David L Bartlett; Julianne Holleran; Kevin Schombert; Juliann E Kosovec; Merrill J Egorin; Jan H Beumer
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 2.  Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.

Authors:  Jan H Beumer; Edward Chu; Carmen Allegra; Yusuke Tanigawara; Gerard Milano; Robert Diasio; Tae Won Kim; Ron H Mathijssen; Li Zhang; Dirk Arnold; Katsuki Muneoka; Narikazu Boku; Markus Joerger
Journal:  Clin Pharmacol Ther       Date:  2018-09-11       Impact factor: 6.875

3.  Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

Authors:  Akiko Kuwahara; Motohiro Yamamori; Kaori Kadoyama; Kohshi Nishiguchi; Tsutomu Nakamura; Ikuya Miki; Takao Tamura; Tatsuya Okuno; Hideaki Omatsu; Toshiyuki Sakaeda
Journal:  J Exp Clin Cancer Res       Date:  2011-10-05

4.  Effects of bolus injection of 5-fluorouracil on steady-state plasma concentrations of 5-fluorouracil in Japanese patients with advanced colorectal cancer.

Authors:  Takao Tamura; Akiko Kuwahara; Kaori Kadoyama; Motohiro Yamamori; Kohshi Nishiguchi; Tsubasa Inokuma; Yoshiji Takemoto; Naoko Chayahara; Tatsuya Okuno; Ikuya Miki; Yoshimi Fujishima; Toshiyuki Sakaeda
Journal:  Int J Med Sci       Date:  2011-07-01       Impact factor: 3.738

5.  Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

Authors:  Akiko Kuwahara; Motohiro Yamamori; Kohshi Nishiguchi; Tatsuya Okuno; Naoko Chayahara; Ikuya Miki; Takao Tamura; Tsubasa Inokuma; Yoshiji Takemoto; Tsutomu Nakamura; Kazusaburo Kataoka; Toshiyuki Sakaeda
Journal:  Int J Med Sci       Date:  2009-09-28       Impact factor: 3.738

Review 6.  Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review.

Authors:  Karoline Freeman; Mark P Saunders; Olalekan A Uthman; Sian Taylor-Phillips; Martin Connock; Rachel Court; Tara Gurung; Paul Sutcliffe; Aileen Clarke
Journal:  BMC Cancer       Date:  2016-07-25       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.